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  ABSTRACT 
Acharya Caraka & Kashyapa have explained that Amlapitta is mainly caused by dietetic 
pattern, mental stress and strain which are related to our digestion. The occurrence 
involves the GIT & chiefly Kapha & Pitta Dosha. The symptoms like Gastritis, peptic 
disorders, hyperacidity, hyperchlorhydria condition resemble that of Amlapitta. 
Aim & Objective: To evaluate the efficacy of Sitamandoor in Specific patients of Amlapitta 
Study Design: The study was conducted on total 18 patients of Amlapitta who completed 
the treatment all along the study period. The patients were selected from the OPD of 
DGMAMC & H, Gadag for respective clinical trial. 
Assessment criteria: Criteria of assessment are set aside on the basis of relief in the signs 
and symptoms of Amlapitta both subjective and objective parameters. 
Results: Among 18 patients 9 responded moderately, 3 markedly improved and 5 
responded well to the treatment. 
Interpretation & Conclusion: Though the criteria of assessment & statistical analysis 
reveal the effect of the study but the fact that the mode of action of the drug is the base of 
the relief in signs & symptoms cannot be ignored. Conclusively the treatment was 
satisfactorily effective in the patients. 
KEY WORDS: Amlapitta, Gastric disorders, peptic ulcers, Sitamandoor. 
INTRODUCTION
In Samhitas, Amlapitta is not mentioned as 
a separate disease entity but there are several 
references in Charaka Samhita1 regarding 
Amlapitta. Madhavakara and Kashyapa have 
described this disease as a separate entity with 
detailed description. Kashyapa2 has accepted the 
involvement of three Doshas in Amlapitta while 
Madhavakara3 has accepted the dominance of 
Pitta in this disease. This disorder is the result of 
Grahani Dosha (Duodenal disease). Charaka and 
Kashyapa have clearly indicated that the Grahani 
Dosha and Amlapitta occur in the persons who fail 
to check the temptation of food. Ajirna 
(Indigestion) after encountering the specific 
Doshas and affinity with specific site may cause 
various diseases4,5,6. Gastritis and non-ulcer 
dyspepsia have been correlated with Amlapitta. 
Patients of gastritis often results into peptic ulcer. 
Purificatory therapy procedure has given been 
importance in this disease by Sangraha 
Granthakara. But it is opted less frequently in 
practice due to more time consumption and 
today’s tedious lifestyle. Acharyas have mentioned 
usage of the drugs which are having Tikta 
Madhura Rasa, Madhura Vipaka, Sheeta Virya and 
Laghu, Ruksha property with Kapha pittahara 
action for the same. 
  A quick sneak into the pathology of the 
disease in GIT gives a brief information that on an 
average 500 ml of gastric juice is secreted per 
meal in the stomach which is acidic in reaction. 
Gastric acid hyper secretion occurs in Zollinger 
Ellison’s Syndrome, Peptic ulcer, G-cell 
hyperplasia etc. The chronic acid hyper secretion 
may lead to several other complications, so it is 
essential to prevent it in prior stage only. In 
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modern science it is managed with antacids, anti-
ulcers and anti-secretory drugs, being Ranitidine 
the most favorite and nowadays second 
generation drugs like omeprazole, H2 blockers can 
successfully control gastric irritation but these 
drugs are having several ill effects like skin rash, 
headache, constipation.7, 8, 9 
There are innumerable herbal and herbo-
mineral preparations available in market for 
Amlapitta. But effective drugs have not yet been 
developed properly for the complete cure of the 
disease. Also the modern medicines have many 
types of complications in this regard. Usually most 
of the cases treated with different formulations 
have the chances of recurrences and also patients 
may become addict to such medicine. In Ayurveda 
classic Sitamandoor is mentioned in Bhaishajya 
Ratnawali which is best indicated in Amlapitta. 
Thus considering the above factors in present 
scenario the clinical study was conducted to 
evaluate the anti-secretory effect of Sitamandoor 
which is easily consumable as it is in Lehya form. 
Aims & Objectives 
The main aim of the present study is to 
assess the anti-secretory action of Sitamandoor in 
Amlapitta. 
Preparation of Trial Drug10 
The author of Bhaishajya ratnavali has 
explained the Sitamandoor under Amlapitta 
prakarana to treat Amlapitta with same 
ingredients as explained in Rasendra sara 
sangraha. The formulation consists of Madhu, 
Triphala, Trikatu, Sukshma Ela, Vayuvidanga, 
Duralabha, Kooth, Lavanga, Madhyashti (all in ¼ 
part), Mandoora Bhasma (1part), Sita (5parts), 
Ghrta (8 parts), Dugdha (16 parts). 
Methodology 
CLINICAL STUDY 
For the Clinical study Sitamandoor is 
administered empty stomach with cold milk as 
Anupana (vehicle) considering its effect on the GIT 
diseases. 
Selection of patients 
Method of collection of data 
 Present study is a prospective clinical 
study. The patients with Amlapitta w.s.r.to 
Hyperchlorhydria within the age group of 15 yrs 
to 60 yrs were selected randomly from O.P.D of 
D.G.M.A.M.C.H. & Research Center after fulfilling 
the inclusion and exclusion criteria irrespective of 
their sex, occupation and socio-economic status.  
Sample size 
 A minimum of 18 patients were taken 
including the dropouts. Among which 17 patients 
completed the treatment. The present study is a 
single group study where in patients were 
assigned one group. It is a simple random 
sampling technique clinical trial.  
Exclusion criteria  
Following were the criteria to exclude the 
patients from the study:  
1.  Patient below 15 and above 60 years of the age.  
2.  Patients with complications like Peptic ulcers, 
Acute or Chronic Gastritis, any secondary 
infections or syndromes and Medical 
Emergencies.  
3.  Pregnant women and lactating mother.  
4.  Any other systemic disorders other than 
Amlapitta.  
5.  Amlapitta patients along with metabolic 
diseases, such as Diabetes and Hypertension.  
6.  Complication which intervenes the course of 
treatment.  
7.  Patients on chemo and radio therapy for 
malignancy.  
Inclusion criteria 
The selection of the patient for clinical 
study was done with following criteria  
1.  Age of patients between 15 to 60 years  
2.  No discriminations of chronicity and severity 
of disease 
3. Patients of classical Amlapitta symptoms 
irrespective of gender, caste,  occupation 
and economic status.  
4. Amlapitta of any Dosha anubandha (associated 
Doshas).  
5.  Cases of Amlapitta in whom treatment was 
interrupted are considered with a  period of 
one week gap and then selected for treatment.  
Criteria of Diagnosis  
 Diagnosis is made on the basis of classical 
symptoms and presence of prominent feature of 
Amlapitta. 
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Study design: Clinical observational study Simple 
random sampling techniques. 
Posology: Sitamandoor started with 2gm and day 
to day increase 1-1 gm till 12gm.once in a day, 
empty stomach for 30 days with cold milk as 
Anupana.  
Study duration: 45 days study  
Follow up: 15 days. 
Criteria for Assessment: The symptoms as per 
the classical norms and the investigations as per 
the modern norms are both considered subjective 
and objective parameters. They are mentioned in 
the table1.1 below. 
Table 1: Showing the Various Criterion for 
Assessment of Amlapitta 
The Symptoms of Amlapitta in classical text 
are as follows11, 12 
 Avipaka (indigestion) 
 Aruchi (anorexia) 
 Gourava (feeling of heaviness in the body)  
 Hrudaha (burning sensation in chest) 
 Utklesha(nausea) 
 Chardi (vomiting) 
 Amlodgara, Tiktodgara (erectations of 
sour/bitter taste) 
 Klama (exhaustion without exertion) 
 Daha (burning sensation in throat) 
 Agnimandya (loss of appetite) 
Investigations 
 Hb % 
 Total RBC count 
 Total WBC count 
 ESR 
 Stool analysis (if necessary) 
The effect of the drug under trial was 
based mainly on the improvement in the cardinal 
signs and symptoms of disease as mentioned 
above. To give some objectivity, from the above 
given classical signs & symptoms the score was 
assigned to each of the major symptoms of the 
disease like Daha, Amlodgara, Shula, Chhardi and 
Avipaka. These 5 symptoms were taken for 
consideration for grading criteria, they were given 
scores & on the basis of before and after treatment 
score, the statistical analysis was done using 
paired ‘t’ test and S.D., S.E. and P value were 
calculated.  
GRADING CRITERIA 
Table 1.2: showing the grading criteria of the 
assessment parameters 
Daha Absent : 0  
Mild : 1 
Moderate : 2 
Severe : 3 
Chardi Absent : 0  
Mild : 1 
Moderate : 2 
Severe : 3 
Shoola Absent : 0  
Mild : 1 
Moderate : 2 
Severe : 3 
Avipaka Absent : 0  
Mild : 1 
Moderate : 2 
Severe : 3 
Amlodgara Absent : 0  
Mild : 1 
Moderate : 2 
Severe : 3 
Aruchi Absent : 0  
Mild : 1 
Moderate : 2 
Severe : 3 
Gaurava Absent : 0  
Mild : 1 
Moderate : 2 
Severe : 3 
Utklesha Absent : 0  
Mild : 1 
Moderate : 2 
Severe : 3 
Tiktodgar Absent : 0  
Mild : 1 
Moderate : 2 
Severe : 3 
Klama Absent : 0  
Mild : 1 
Moderate : 2 
Severe : 3 
Assessment of result: The subjective and 
objective parameters of base line data to post 
medication as mentioned above were compared 
for assessment of result. All the result were 
analyzed statistically. 
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Observation & Result 
EFFECT OF THERAPY 
Total 17 patients completed their 
treatment with Shamana chikitsa by administering 
Sitamandoor group. Sitamandoor was given for 1 
month in a dose of 2 gm tds for 1 month. 
Observations are being presented in 
different parts i.e. effect on cardinal symptoms, 
effect on associated symptom, effect on Agnidushti 
and Kostha Vikriti. Total effect of therapies was 
assessed on the basis of above effect which is also 
being presented in the tables below. 
The cardinal symptoms and associated 
symptoms were exhibited in different percentage 
in the patients. Generally all the patients showed 
Shirahshula and Gaurava. 65.36% patients showed 
Bhrama and 51.60% patients showed Klama as 
associated symptoms. 
Table 1.3: Showing the no. of patients presenting the cardinal + other signs & symptoms 
Complaints No. of patients Percentage of patients 
Avipaka 17 94.45 
Aruchi 14 77.78 
Gaurava 10 55.56 
Hritdaha 15 83.34 
Utklesha 12 66.67 
Amlodgar 15 83.34 
Tiktodgar 08 44.45 
Kanthadaha 15 83.34 
Klama 10 55.56 
Chardi 08 44.45 
Table 1.4 Showing the Assessment Parameters with Their Grading 
S.No Signs/Symptoms Before treat After treat  After follow up 
1 Daha 15 10 8 
2 Shoola 14 8 6 
3 Chardi 08 4 4 
4 Avipaka 17 7 6 
5 Amlodgar 15 6 5 
Table 1.5: Showing the Grading of Associated Symptoms 
S.No Signs/Symptoms Before treat After treat  After follow up 
1 Aruchi 14 9 8 
2 Gaurava 10 5 4 
3 Utklesha 12 7 6 
4 Klama 10 4 4 
5 Tiktodgar 08 3 3 
Table 1.6 Showing Effect of Sitamandoor on cardinal symptoms of 17 patients of Amlapitta 
Data Daha Amlodgara Shula Chhardi Avipaka 
N 17 17 17 17 17 
B.T.  2.58 2.88 2.35 1.58 2.64 
A.T. 1.00 0.94 0.76 0.47 0.52 
% Relief 61.24 67.36 67.65 70.25 80.30 
S.D. 0.50 0.48 0.79 0.52 0.78 
S.E. 0.12 0.11 0.19 0.12 0.12 
‘t’ 13.16 17.09 08.31 09.75 11.72 
P <0.001 <0.001 <0.001 <0.001 <0.001 
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Table 1.7 Showing Effect of Sitamandoor on Associated symptoms of 17 patients of Amlapitta 
Data Klama Shirahshula Gaurava Bhrama  
N 07 17 17 10 
B.T.  02 02 02 02 
A.T. 1.71 1.29 0.94 1.70 
% Relief 14.50 35.50 53.00 15.00 
S.D. 0.48 5.68 0.42 0.48 
S.E. 0.18 0.16 0.10 0.15 
‘t’ 1.55 4.37 10.50 2.00 
P >0.05 <0.001 <0.001 >0.05 
Table 1.8 Showing Effect of Sita mandoor on Agnidushti of 17 patients of Amlapitta 
Data Aruchi Agnimandya 
N 17 17 
B.T.  02 02 
A.T. 0.47 0.52 
% Relief 76.50 74.00 
S.D. 0.51 0.51 
S.E. 0.12 0.12 
‘t’ 12.66 12.25 
P <0.001 <0.001 
Table 1.9 Showing Overall effect of Sitamandoor in 17 patient of Amlapitta 
Total Effect  No. of Patients %  
Complete remission 00 00 
Markedly improved  03 17.62 
Moderately improved  09 52.92 
Improved  05 29.40 
Unchanged  00 00.00 
17.62% patients showed marked improvement, 52.92% patients showed moderate improvement 
while 29.40% patients showed slight improvement. There was no complete remission in any of these 
patients and also no side effects were observed during the entire study duration. 
STATISTICAL ANALYSIS OF CRITERIAS FOR ASSESSMENT 
Table 2.0: Showing the Subjective & Objective Statistical Gradings 
Symptoms  BT AS AF 
Daha 3.12 1 0.4 
Amlodgara 3.145 0.94 0.3 
Shula 2.67 0.76 0.5 
Chardi 2.04 0.47 0.6 
Avipaka 2.94 0.52 0.4 
Klama 2 1.71 0.6 
Shirahashula 2 1.29 0.3 
Gaurava 2 0.94 0.4 
Bhrama 2 1.7 0.8 
Aruchi 2 0.47 0.9 
Agnimandya 2 0.52 0.6 
Table 2.1: Showing the Subjective & Objective Statistical Gradings 
Sl. 
No. 
OPD 
No. 
HB% RBC Count WBC Count ESR 
BT AT BT AT BT AT BT AT 
1 355 11.5 12.6 4.2 4.6 9000 8300 14 12 
2 477 10.5 12.5 4.1 4.7 8300 7900 16 14 
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3 1024 11.5 12.6 4.4 4.7 8600 7900 18 13 
4 1038 10.5 11.6 4.1 4.7 8400 8100 23 16 
5 1155 11.5 12.5 4.2 4.7 7900 7400 22 16 
6 1167 09.5 11.6 4.1 4.3 9000 8600 14 12 
7 1275 11.3 12.4 3.8 4.3 8100 7900 18 14 
8 1391 11.5 12.0 4.1 4.9 7800 7300 20 16 
9 1614 10.3 11.5 4.0 4.1 8900 8100 14 12 
10 1893 11.6 12.5 3.8 4.4 8300 7600 16 12 
11 1928 11.5 12.9 4.2 4.7 7400 7200 13 10 
12 1943 10.3 12.1 4.2 4.7 8300 8100 16 13 
13 1994 11.0 12.4 4.1 4.6 7200 6900 24 16 
14 2328 11.5 12.5 4.0 4.2 8300 8100 25 18 
15 2383 10.5 11.5 3.9 4.1 8900 8700 16 12 
16 2330 11.2 12.4 4.1 4.2 8400 8100 14 12 
17 2321 11.4 10.3 4.0 4.6 8700 8200 21 18 
DISCUSSION 
Statistical point of view: 17.62% patients 
showed marked improvement, 52.92% patients 
showed moderate improvement while 29.9% 
showed slight improvement and no patient 
remains unchanged.  
Drug action point of view13,14,15: The 
contents of Sitamandoor are Laghu and Ruksha in 
property. There is increase of Drava Guna in 
Amlapitta. Kledaka Kapha and Pachaka Pitta are 
Drava in dominancy. So Laghu-Ruksha Guna 
performs the function of Dravansha - Shoshana. 
Other functions of Laghu, Ruksha Guna are 
Lekhana, Stambhana and Ropana. This 
formulation is Tikta dominant and it performs the 
functions of Pachana rather than Deepana. Tikta 
Rasa helps in Shoshana of Jala dominant 
substances which includes Kleda, Meda, Vasa, 
Lasika, Pitta and Kapha.  
Tikta-Kashaya Rasa helps in pacifying the 
Kapha-pitta both.  
In these two rasa Tikta is better as it is 
Laghu and it does not stagnate the Ama. It 
performs the function of Pitta-Sleshma Shoshana 
as described by Charaka. “Tikta Vishadyati” can be 
observed throughout gastrointestinal tract (G.I.T.) 
All contents of this formulation balance 
the each others drawback. As Tikta is Avrishya and 
Vatakaraka but Duralabha and Kooth are opposite 
to it. Because of Tikta rasa and Laghu- Ruksha 
Property there are chances of constipation but 
‘Triphala’ is added so there is Anulomana 
property. Ksheera also plays an important role as 
it is Pathya for Amlapitta.  
CONCLUSION 
 Amlapitta a foremost disease can be 
understood as the normal functioning of 
the Agni, Pachaka pitta (the secreto 
enzymatic functioning of GIT) where diet 
plays a vital role. It is chronic in nature. 
 The drug under trial Sitamandoor was 
effective in hyperacidity condition. It 
relieved hyperacidity in 3 patients 
remarkably, 9 moderately & 5 patients 
ended with improving well. 
 It was observed that patients taking 
Sitamandoor were relieved of their 
symptoms after 15 - 21 days drug regimen. 
It was observed that the drug is 
specifically effective in early cases of 
Amlapitta. This beneficial effect of trial 
drug may be due to Tikta Rasa, Laghu - 
Ruksha property and Kapha pittahara 
action of the combined drug of this 
preparation. 
 Sitamandoor exhibited specific role in 
relieving the cardinal signs & symptoms of 
Amlapitta. 
 These findings have proved that 
Sitamandoor has got specific therapeutic 
activity in the treatment of Amlapitta. 
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